Founded in 2010, Triveritas USA is headed by Dr. Victoria Lewis, Technical and Business Development Director, and Dr. Dave Petrick, Regulatory Director.
Victoria began her career in human pharma and has built a long and successful career in drug development, including 16 years in the animal health sector. She has worked for both pharmaceutical companies and contract research organisations.
Dave has worked in Animal Health his entire career having participated in the development and approval of numerous Animal Health drugs, biologicals and pesticides for both companion animals and food species.
Donna Mattson has worked in veterinary biologicals in Canada and offers an interface between the EU and North American regulatory systems from within the Triveritas global regulatory affairs team.
Triveritas USA and Canada, work alongside Triveritas UK, in responding to enquiries from existing and new clients concerning US and Canadian regulatory matters. Importantly, we can provide Parallel Scientific Advice to clients, allowing the regulatory authorities in Europe and North America to exchange views during the development phase of a new medicine.
In addition, clinical studies can be conducted and managed to the same procedures and standards in both the USA, Canada and Europe, so that comparable acceptable data can be obtained, and thus be pivotal in the global development program for a client.
Triveritas USA and Canada continues to expand as demand for services grows.
To contact Triveritas USA click here.